Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 46,700 $ 780,292
Prepaid expenses 583,532 747,842
Advance to related parties 25,000
Total Current Assets 655,232 1,528,134
Cash and marketable securities held in Trust Account 287,534,744 287,491,254
TOTAL ASSETS 288,189,976 289,019,388
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)    
Current liabilities - accounts payable and accrued expenses 2,561,750 106,477
Warrant liability 29,205,001 22,862,501
Deferred underwriting fee payable 10,062,500 10,062,500
Total Liabilities 41,829,251 33,031,478
Commitments
Class A common stock subject to possible redemption 28,750,000 and 25,098,791 shares at redemption value at March 31, 2021 and December 31, 2020, respectively 287,500,000 250,987,908
Stockholders’ Equity (Deficit)    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Class A common stock, $0.0001 par value; 75,000,000 shares authorized; no shares and 3,651,209 issued and outstanding (excluding 24,136,072 and 25,098,791 shares subject to possible redemption) at March 31, 2021 and December 31, 2020, respectively 365
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,833,333 shares issued and outstanding 383 383
Class C common stock, $0.0001 par value; 15,000,000 shares authorized; 5,750,000 shares issued and outstanding 575 575
Additional paid-in capital 24,138 6,650,386
Accumulated deficit (41,164,371) (1,651,707)
Total Stockholders’ Equity (Deficit) (41,139,275) 5,000,002
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) $ 288,189,976 $ 289,019,388